Accovion Launches New Subsidiary in France

FRANKFURT & ESCHBORN, Germany--Accovion, a leading independent European full-service Contract Research Organization, headquartered in Frankfurt (Eschborn), Germany, announced today the establishement of a new subsidiary in Lyon, France, as it continues its expansion across Europe. Together with offices in Italy, Poland, Russia, Romania, Spain, Czech Republic and United Kingdom, Accovion is now able to present itself with eight subsidiaries and overall coverage of 20 European countries.

Ivana Waller, the COO of Accovion Group states: "France represents a key strategic territory in terms of conducting clinical trials in Europe and therefore the new French subsidiary reinforces our mission to better serve our clients by offering a broader European footprint. The rationale for setting up the company specifically in Lyon is based on the fact that this region has a high concentration of pharmaceutical and biotech companies, as well as various related support companies engaged in the field of life sciences. This provides us with proximity to our clients, access to experienced talent pool, abundant clinical research sites as well as access to key opinion leaders." She adds: "The city of Lyon provides an active support to the life sciences companies, including many networking opportunities and rigorous support and promotion of the local Bio-cluster. In addition, the city is generally business friendly and progressive."

The local entity will be headed by Dr. Olivier Humbey, who was appointed Country Director, France on 1 November 2014. Dr. Humbey, French native, will be spearheading not only the company's activities in France, but given his extensive scientific background, well-networked position in the industry and abundant experience, strongly support the strategies of the entire Accovion Group.

"It is with a tremendous pleasure that I am joining the Accovion Group and its growing international team. I look very much forward to bringing my experience in the clinical research field to pursue Accovion's successful development and build on its excellent reputation for the best of our clients' developments. Together we will ensure that our French operations are integrating the recognized quality services provided by Accovion on the EU market", emphasizes Dr. Humbey with regard to his new responsibilities.

Please visit www.accovion.com for further information.

Contacts

Accovion
Sonja Riebel
Marketing & Communication
Phone: +49 6196 7709 339
e-Mail: [email protected]

 

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

Galapagos is selling off its contract research organization Fidelta for $37 million to Polish life science company Selvita.

Decentralized study company Medable has raised a large $91 million funding round as it continues to ramp up the deals in 2020.

Biotech IPOs are up over 40% year-to-date, but today’s markets have rewritten the rules for going public. Find out the new best practices for IPOs.